Commentary
Clinical Pharmacology & Therapeutics (2007) 81, 801–805. doi:10.1038/sj.clpt.6100227
"Personalized Medicine: Elusive Dream or Imminent Reality?": A Commentary
A Roses1
1Genetics Research and Development, GlaxoSmithKline, Research Triangle Park, North Carolina, USA
Correspondence: A Roses, (allen.d.roses@gsk.com)
Top of page
Abstract
I was invited to comment on the article in this issue by Larry Lesko, "Personalized Medicine: Elusive Dream or Imminent Reality?",1 especially with respect to three questions. There are several possible approaches to discussing these questions. One is to simply answer the question as directly and succinctly as possible; another is to expand on the questions. For the purpose of this Commentary, I try to do both.
